Transapical aortic valve implantation - What have we learnt? Quo vadis?

Transapical aortic valve implantation - What have we learnt? Quo vadis?

Author Carsten J. Beller

Abstract
After Alain Cribier pioneered in 2002 the transfemoral approach to transcutaneous aortic valve implantation (TAVI) (1), the Leipzig Heart Center was the first to perform a transapical TAVI in December 2004. TAVI is now a treatment for patients with severe aortic stenosis, that had previously been refused for surgery due to prohibitively high surgical risk (2,3). This year we celebrate the 10-year anniversary of this technology, which was inevitably highly controversial in the beginning. The number of TAVI procedures have increased worldwide drastically and in particular in Germany, where now they account for one-third of all isolated aortic valve operations.

Full Text: PDF

see also original article: Transapical aortic valve implantation - The Leipzig experience

http://www.annalscts.com/article/view/491/908

Trackbacks

Trackback URL for this entry is: http://blog.case.edu/CDT/mt-tb.cgi/26648

Comments

gravatar

Posted by: paul
Posted on: November 9, 2012 12:29 AM


see original article: Transapical aortic valve implantation - The Leipzig experience

http://www.annalscts.com/article/view/491/908

Post a comment





If you have entered an email address in the box, clicking this checkbox will subscribe your email address to this entry so that you are notified if any updates or additional comments occur on the entry.